The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
[gamma-Linolenic Acid co-treated with Iodine co-treated with Selenium] results in increased expression of and results in increased localization of CLDN5 protein; [gamma-Linolenic Acid co-treated with Iodine] results in increased expression of and results in increased localization of CLDN5 protein; [Selenium co-treated with Iodine] results in increased expression of and results in increased localization of CLDN5 protein; Iodine results in increased expression of and results in increased localization of CLDN5 protein
[[Iodine deficiency co-treated with sodium perchlorate] affects the susceptibility to hexabromocyclododecane] which results in decreased expression of CYB5A protein
Iodine results in decreased activity of DIO1 protein Methylnitrosourea inhibits the reaction [Iodine results in increased expression of DIO1 mRNA] Selenium inhibits the reaction [Iodine results in decreased activity of DIO1 protein]; Selenium inhibits the reaction [Iodine results in decreased expression of DIO1 mRNA]
Iodine results in increased expression of FOS mRNA; Iodine results in increased expression of FOS protein [Selenium co-treated with Iodine] results in increased expression of FOS mRNA; [Selenium co-treated with Iodine] results in increased expression of FOS protein
[[Iodine deficiency co-treated with sodium perchlorate] affects the susceptibility to hexabromocyclododecane] which results in decreased expression of FTCD protein
[[Iodine deficiency co-treated with sodium perchlorate] affects the susceptibility to hexabromocyclododecane] which results in increased expression of GAMT protein
[Iodine co-treated with Dibutyl Phthalate] results in increased expression of IFNG protein; pyrazolanthrone inhibits the reaction [[Iodine co-treated with Dibutyl Phthalate] results in increased expression of IFNG protein]
[Iodine co-treated with Dibutyl Phthalate] results in increased expression of IL17A protein; pyrazolanthrone inhibits the reaction [[Iodine co-treated with Dibutyl Phthalate] results in increased expression of IL17A protein]
[Iodine co-treated with Dibutyl Phthalate] results in increased expression of IL6 protein; pyrazolanthrone inhibits the reaction [[Iodine co-treated with Dibutyl Phthalate] results in increased expression of IL6 protein]
Iodine results in increased expression of JUN mRNA; Iodine results in increased expression of JUN protein [Iodine co-treated with Dibutyl Phthalate] results in increased phosphorylation of and results in increased activity of JUN protein; [Selenium co-treated with Iodine] results in increased expression of JUN mRNA; [Selenium co-treated with Iodine] results in increased expression of JUN protein
[gamma-Linolenic Acid co-treated with Iodine co-treated with Selenium] results in increased expression of and results in increased localization of OCLN protein; [gamma-Linolenic Acid co-treated with Iodine] results in increased expression of and results in increased localization of OCLN protein; [Selenium co-treated with Iodine] results in increased expression of and results in increased localization of OCLN protein; Iodine results in increased expression of and results in increased localization of OCLN protein
[[Iodine deficiency co-treated with sodium perchlorate] affects the susceptibility to hexabromocyclododecane] which results in increased expression of PON1 protein; [Iodine deficiency co-treated with sodium perchlorate] results in decreased expression of PON1 protein
[[Iodine deficiency co-treated with sodium perchlorate] affects the susceptibility to hexabromocyclododecane] which results in increased expression of PON2 protein
[Iodine co-treated with Dibutyl Phthalate] results in increased expression of SERPINA7 protein; pyrazolanthrone inhibits the reaction [[Iodine co-treated with Dibutyl Phthalate] results in increased expression of SERPINA7 protein]
Iodine results in increased expression of SLC26A4 mRNA Methylnitrosourea promotes the reaction [Iodine results in increased expression of SLC26A4 mRNA]
2,2',4,4'-tetrabromodiphenyl ether inhibits the reaction [SLC5A5 protein results in increased uptake of Iodine]; 5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [SLC5A5 protein results in increased uptake of Iodine]; [[Butyrates co-treated with decitabine] results in increased expression of SLC5A5 mRNA] which results in increased uptake of Iodine; captax inhibits the reaction [SLC5A5 protein results in increased uptake of Iodine]; cypermethrin inhibits the reaction [SLC5A5 protein results in increased uptake of Iodine]; decamethrin inhibits the reaction [SLC5A5 protein results in increased uptake of Iodine]; Dibutyl Phthalate inhibits the reaction [SLC5A5 protein results in increased uptake of Iodine]; Indomethacin inhibits the reaction [SLC5A5 protein results in increased uptake of Iodine]; mancozeb inhibits the reaction [SLC5A5 protein results in increased uptake of Iodine]; polymarcine inhibits the reaction [SLC5A5 protein results in increased uptake of Iodine]; potassium perchlorate inhibits the reaction [SLC5A5 protein results in increased uptake of Iodine]; sodium perchlorate inhibits the reaction [SLC5A5 protein results in increased uptake of Iodine]; sodium thiocyanate inhibits the reaction [SLC5A5 protein results in increased uptake of Iodine]; triclocarban inhibits the reaction [SLC5A5 protein results in increased uptake of Iodine] SLC5A5 protein affects the transport of Iodine
[gamma-Linolenic Acid co-treated with Iodine co-treated with Selenium] results in increased expression of and results in increased localization of TJP1 protein; Iodine results in increased expression of and results in increased localization of TJP1 protein
efavirenz promotes the reaction [TSHB protein affects the abundance of Iodine]; Nevirapine promotes the reaction [TSHB protein affects the abundance of Iodine]; sodium perchlorate inhibits the reaction [efavirenz promotes the reaction [TSHB protein affects the abundance of Iodine]]; sodium perchlorate inhibits the reaction [Nevirapine promotes the reaction [TSHB protein affects the abundance of Iodine]] [Iodine deficiency co-treated with sodium perchlorate] results in increased secretion of TSHB protein Iodine deficiency results in increased secretion of TSHB protein